Cantargia AB (publ) (STO:CANTA)
Sweden · Delayed Price · Currency is SEK 1.840
-0.060 (-3.16%)
Jul 24, 2026, 5:29 PM CET
Cantargia AB Market Cap
Cantargia AB has a market cap or net worth of 472.36 million as of July 24, 2026. Its market cap has decreased by -36.67% in one year.
Market Cap
472.36M
Enterprise Value
214.33M
Revenue
317.21M
Ranking
n/a
PE Ratio
2.97
Stock Price
1.84
ChartMarket Cap Chart
Since March 17, 2015, Cantargia AB's market cap has increased from 120.55M to 472.36M, an increase of 291.83%. That is a compound annual growth rate of 12.78%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 23, 2026 | 472.36M | -54.60% |
| Dec 30, 2025 | 1.04B | 147.63% |
| Dec 30, 2024 | 420.15M | -38.81% |
| Dec 29, 2023 | 686.62M | 33.50% |
| Dec 30, 2022 | 514.32M | -72.19% |
| Dec 30, 2021 | 1.85B | -68.27% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SynAct Pharma AB | 1.02B |
| AlzeCure Pharma AB | 910.12M |
| Infant Bacterial Therapeutics AB | 875.64M |
| Xspray Pharma AB | 715.99M |
| Oncopeptides AB | 648.27M |
| FluoGuide | 536.26M |
| Corline Biomedical AB | 454.72M |
| Mendus AB | 398.77M |